B F C Financial Cp B (BFCFB) 3.3900 $BFCFB BBX Capital

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
B F C Financial Cp B (BFCFB) 3.3900 $BFCFB

BBX Capital Real Estate Completes the Sale of Its North Flagler Properties in West Palm Beach, Florida
Marketwired - Mon May 18, 7:02AM CDT
BBX Capital Real Estate, a division of BBX Capital Corporation ("BBX Capital," "BBX," and/or the "Company" (NYSE: BBX) announced today that it had completed its previously announced sale of two properties located in West Palm Beach, Florida (the "North Flagler properties" to a third party on May 15, 2015.
BBX: 15.99 (-0.12)

BFC Financial Corporation Reports Financial Results for the First Quarter, 2015
Marketwired - Mon May 11, 7:02AM CDT
BFC Financial Corporation ("BFC" or the "Company" (OTCQB: BFCF) (OTCQB: BFCFB) reported financial results for the three month period ended March 31, 2015.
BBX: 15.99 (-0.12)

BBX Capital Corporation Reports Financial Results for the First Quarter, 2015
Marketwired - Mon May 11, 7:02AM CDT
BBX Capital Corporation ("BBX Capital," and/or the "Company" (NYSE: BBX) reported financial results for the three months ended March 31, 2015.
BBX: 15.99 (-0.12)

BBX Capital Corporation Takes Ownership of Florida Asset Resolution Group
Marketwired - Thu May 07, 7:01AM CDT
BBX Capital Corporation ("BBX Capital," "BBX," and/or the "Company" (NYSE: BBX) announced today that it has paid the remaining balance of $6.1 million to BB&T Corporation ("BB&T", on the original $285 million preferred interest in the Florida Asset Resolution Group ("FAR" held by BB&T. As a result, BBX Capital is now the sole owner of FAR which held approximately $94.8 million of assets at March 31, 2015.
BBT: 39.23 (+0.51), BBX: 15.99 (-0.12)

BFC Financial Corporation Successfully Completes Tender Offer for Shares of BBX Capital Corporation's Class A Common Stock
Marketwired - Thu Apr 30, 7:30AM CDT
BFC Financial Corporation ("BFC" (OTCQB: BFCF) (OTCQB: BFCFB) announced today that it has successfully completed its tender offer to purchase 4,771,221 shares of Class A Common Stock of BBX Capital Corporation ("BBX Capital" (NYSE: BBX) at a cash purchase price of $20.00 per share, net to the seller in cash (less any applicable withholding taxes and without interest). The tender offer, which commenced on March 20, 2015, expired at 5:00 p.m., New York City time, on April 24, 2015.
BBX: 15.99 (-0.12)

BFC Financial Corporation Announces Preliminary Results of Its Tender Offer for Shares of BBX Capital Corporation's Class A Common Stock
Marketwired - Mon Apr 27, 8:13AM CDT
BFC Financial Corporation ("BFC" (OTCQB: BFCF) announced today the preliminary results of its tender offer to purchase up to 4,771,221 shares of Class A Common Stock of BBX Capital Corporation ("BBX Capital" at a cash purchase price of $20.00 per share. The tender offer expired at 5:00 p.m., New York City time, on Friday, April 24, 2015.
BBX: 15.99 (-0.12)

BBX Capital Corporation Contracts to Sell Its Interests in North Flagler Property in West Palm Beach, Florida
Marketwired - Tue Apr 21, 3:11PM CDT
BBX Capital Real Estate, a division of BBX Capital Corporation ("BBX Capital," "BBX," and/or the "Company" (NYSE: BBX) announced today that a third party purchaser has entered into contracts to purchase two North Flagler properties located in West Palm Beach, Florida.
BBX: 15.99 (-0.12)

BFC Financial Corporation Announces Agreement for $80 Million Loan to Finance BBX Capital Corporation Tender Offer
Marketwired - Fri Apr 17, 3:11PM CDT
BFC Financial Corporation ("BFC" (OTCQB: BFCF) announced today that it has entered into a Loan Agreement and Promissory Note pursuant to which a wholly owned subsidiary of Bluegreen Corporation ("Bluegreen" has agreed to provide an $80 million loan to BFC which may be used to fund BFC's previously announced tender offer to purchase up to 4,771,221 shares of Class A Common Stock of BBX Capital Corporation ("BBX Capital" at a cash purchase price of $20.00 per share. Amounts outstanding on the loan will bear interest at a rate of 10% per annum. Payments of interest only will be required on a quarterly basis, with all outstanding amounts being due and payable at the end of five years. BFC will be permitted to prepay the loan in whole or in part at any time, and prepayments will be required, to the extent necessary, in order for Bluegreen or its subsidiaries to remain in compliance with covenants under their outstanding indebtedness. BFC and BBX Capital own 54% and 46%, respectively, of Woodbridge Holdings, LLC, which owns 100% of Bluegreen.
BBX: 15.99 (-0.12)

BBX Capital Acquires Kencraft Candy
Marketwired - Mon Apr 06, 3:07PM CDT
BBX Sweet Holdings, a wholly-owned subsidiary of BBX Capital Corporation ("BBX Capital" (NYSE: BBX), announced today that it has acquired the assets of Kencraft, Inc. "Kencraft Candy."
BBX: 15.99 (-0.12)

BBX Capital Special Committee Issues Statement Regarding BFC Financial Corporation Announcement of Cash Tender Offer for Shares of BBX Capital Class A Common Stock
Marketwired - Tue Mar 17, 3:29PM CDT
The special committee of independent directors (the "Special Committee" of the board of directors of BBX Capital Corporation (NYSE: BBX) ("BBX Capital" announced today that it has been informed that its majority shareholder, BFC Financial Corporation ("BFC", intends to make a tender offer to acquire up to 4,771,221 shares of the Class A common stock (including the associated preferred share purchase rights) of BBX Capital not otherwise owned by BFC at a price of $20.00 in cash per share. Presently, BFC owns approximately 51% of the outstanding shares of BBX Capital's Class A common stock.
BBX: 15.99 (-0.12)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading